Reply to Jain et al.: Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System: Still a Great Need to "EMPROVE"
- PMID: 31580712
- PMCID: PMC6999111
- DOI: 10.1164/rccm.201909-1798LE
Reply to Jain et al.: Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System: Still a Great Need to "EMPROVE"
Comment on
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.Am J Respir Crit Care Med. 2019 Dec 1;200(11):1354-1362. doi: 10.1164/rccm.201902-0383OC. Am J Respir Crit Care Med. 2019. PMID: 31365298 Free PMC article. Clinical Trial.
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System: Still a Great Need to "EMPROVE".Am J Respir Crit Care Med. 2020 Feb 1;201(3):391. doi: 10.1164/rccm.201908-1667LE. Am J Respir Crit Care Med. 2020. PMID: 31580716 Free PMC article. No abstract available.
References
-
- Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, et al. EMPROVE Study Group. Improving lung function in severe heterogenous emphysema with the Spiration® valve system (EMPROVE): a multicenter, open-label, randomized, controlled trial. Am J Respir Crit Care Med. 2019;200:1354–1362. - PMC - PubMed
-
- Marchetti N, Criner GJ. Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med. 2015;36:592–608. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical